013: Molecular stratification of low-risk prostate cancer patients for improved therapy decision making

HIPO Investigator:

Dr. Holger Sültmann

Dr. Boris Hadaschik

Dr. Carsten Grüllich

Prof. Wilfried Roth

Prof. Stefan Duensing

Supported by: HIPO/POP

Entity: prostate cancer

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline